发明名称 PYRROLOPYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
摘要 A compound having the structure wherein, R1 is a substituted or unsubstituted alkyl, wherein the substituent is hydroxyl, dihydroxy, carboxyl, -C(=O)NRaRb, -NRaRb, -NRaC(=O)NRaRb, -NRaC(=O)ORa, -OC(=O)NRaRb, or -NHC(=O)Ra; R2 is hydrogen or a substituted or unsubstituted alkyl, wherein the substituent is hydroxyl, dihydroxyl, carboxyl, -C(=O)NRaRb, -NRaRb, -NRaC(=O)NRaRb, -NRaC(=O)ORa, -OC(=O)NRaRb, or -NHC(=O)Ra, or R1, R2 and N together form a substituted piperazine, substituted azetidine ring, or a pyrrolidine ring substituted with -(CH2)2OH or -CH2C(=O)OH; R3 is a substituted or unsubstituted phenyl or a 5-6 membered heteroaryl ring, wherein the substituent is halogen, hydroxyl, cyano, (C1-C15)alkyl, (C1-C15)alkoxyl, or -NRaRb; R4 is hydrogen or substituted or unsubstituted (C1-C15)alkyl; R5 is -(CH2)mOR6, -CHNOR7, -C(=O)NR8R9, -(CH2)mC(=O)OR10, -(CH2)kC(=O)NR11R12.
申请公布号 EP1467995(B1) 申请公布日期 2010.05.19
申请号 EP20020805644 申请日期 2002.12.20
申请人 OSI PHARMACEUTICALS, INC. 发明人 CASTELHANO, ARLINDO, L.;MCKIBBEN, BRYAN;STEINIG, ARNO, G.
分类号 C07D487/04;A61K31/519;A61P1/04;A61P1/12;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P11/06;A61P13/00;A61P17/00;A61P17/04;A61P19/02;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P37/08;A61P43/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址